A new clinical trial led by the University Hospital of Ferrara, in collaboration with Università degli Studi di Ferrara, focuses on how physical exercise and cognitive training may improve the quality of life for elderly adults aged 65 and older. With a recruitment phase currently active, the study combines behavioral interventions alongside or independent of medication to explore their efficacy in improving well-being.
The trial brings promising opportunities for regulatory teams, clinical researchers, and healthcare providers aiming to enhance elderly care and develop evidence-based intervention models.
In this article
- What are the key details of the trial?
- Who is the target population?
- How is the study conducted?
- What are the expected outcomes?
- Frequently Asked Questions (FAQ)
- Conclusion and next steps
- Disclaimer
- Further information
What are the key details of the trial?
The trial is conducted under the sponsorship of the University Hospital of Ferrara and Università degli Studi di Ferrara. It is designed as a behavioral study focusing on the impact of physical and cognitive interventions on elderly individuals’ quality of life. Importantly, these interventions may also interact with or function independently of medication regimens.
The study’s recruitment efforts are ongoing as of November 24, 2025, providing an opportunity for broader participation and data collection.
Who is the target population?
The project is specifically aimed at elderly adults aged 65 and above. This population is often at risk of declines in cognitive and physical function, making them an ideal group for testing the efficacy of such interventions.
Through methodical evaluation, the study seeks to address how certain behavioral modifications impact both mental and physical health in this demographic.
How is the study conducted?
The study leverages exercise training programs designed to enhance physical fitness and cognitive function. These programs may be combined with medication or conducted independently, allowing for the assessment of standalone and combined effects.
Participants are assessed over specific time intervals with metrics evaluating improvements in quality of life, functionality, and cognitive performance. The rigorous methodology ensures both reliability and safety, consistent with regulatory standards.
What are the expected outcomes?
Researchers anticipate that the trial will provide robust data to illustrate the effectiveness of exercise and cognitive training on improving elderly adults’ quality of life. These insights may inform future guidelines, intervention programs, and healthcare policies tailored to aging populations.
Additionally, the trial may uncover whether behavioral interventions can mitigate or complement medication use in addressing age-related challenges.
Frequently Asked Questions (FAQ)
- What is the main focus of the clinical trial?
The trial examines the effects of physical and cognitive training on elderly adults’ quality of life, with additional variables for medication. - Who can participate in the trial?
Adults aged 65 and above are eligible to participate, subject to inclusion criteria determined during recruitment. - What results are the researchers hoping to achieve?
The study aims to measure improvements in quality of life, functional capacity, and cognitive health among elderly individuals.
Conclusion and next steps
The ongoing trial highlights the potential for behavioral interventions in managing age-related health challenges. By assessing physical exercise and cognitive training, researchers aim to present actionable insights for healthcare professionals, regulatory bodies, and policy developers.
Stakeholders are encouraged to track the study’s progress and review its outcomes as they become available after the recruitment and data analysis phases.
Disclaimer
This article is intended for informational purposes only. It is not legal or medical advice. Stakeholders should consult appropriate professionals or legal advisors for specific guidance.
Further information
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07244536?term=medical+device